Aetna to cover sacroiliac joint fusion under new policy

Angie Stewart -   Print  |

Aetna will cover minimally invasive arthrodesis of the sacroiliac joint under a new policy, which was outlined in a May 29 announcement from medical device company SI-Bone.

Effective May 28, the policy gives Aetna's 22 million medical plan members coverage for SI-Bone's iFuse Implant System when its use is deemed medically necessary.

Aetna's decision was based upon clinical evidence — including five-year results from a prospective study — of the iFuse system's safety and effectiveness, SI-Bone said in a press release.

Click here to view Aetna's policy.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers